Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 26, 1994Proceedings of the National Academy of SciencesOpen Access

Thalidomide is an inhibitor of angiogenesis.

View Full Paper
Ask AI
Bookmark
Share

Authors

RDRobert J. D’AmatoBoston Children's HospitalMLMichael LoughnanBoston Children's HospitalEFEvelyn FlynnBoston Children's Hospital

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

D’Amato et al. (1994) studied this question.

synapsesocial.com/papers/69d817eba2a48916bbbeef70https://doi.org/10.1073/pnas.91.9.4082
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Thalidomide in the treatment of lepra reactions1965 · 533 citations
  2. 2Thalidomide teratogenesis: evidence for a toxic arene oxide metabolite.1981 · 153 citations